EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230

Po-Yi Chou, Chia-Ling Yu, Chiao-Ni Wen, Yu-Kang Tu, Ching-Chi Chi

JAMA Dermatology · 01.11.2024 · 160 (11) · 1192

DOI: 10.1001/jamadermatol.2024.3425 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Dermatology, erschienen am 01.11.2024. Verfasst von Po-Yi Chou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Autoantibodies, Pemphigoid, Bullous. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The correlation between serum levels of autoantibodies against bullous pemphigoid (BP) antigens 180 (BP180) and 230 (BP230) with BP disease severity is unclear.

Objective

To investigate the correlation of anti-BP180 and anti-BP230 immunoglobulin G (IgG) antibody levels with BP disease severity. Data Sources A search was performed of the Cochrane Central Register of Controlled Trials, Embase, and PubMed databases from their respective inception to April 11, 2024. Study Selection Studies evaluating the correlation between serum levels of anti-BP180 or anti-BP230 IgG measured using enzyme-linked immunosorbent assay (ELISA) and disease severity assessed per the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) or BP Disease Area Index (BPDAI) were included. No language or geographic restrictions were imposed. Nearly 0.4% of initially identified studies met the selection criteria. Data Extraction and Synthesis One researcher extracted data and another researcher confirmed data. The risk of bias was independently assessed by these researchers using the Quality Assessment of Diagnostic Accuracy Studies 2 tool, with discrepancies resolved by discussion with a third researcher. A random-effects model meta-analysis and a subgroup analysis were conducted based on the ELISA kit manufacturers. Main Outcomes and Measures Pooled correlation coefficients of antibody levels with ABSIS and BPDAI.

Results

In all, 14 studies with 1226 participants were analyzed. The risk of bias of included studies was generally low. The meta-analysis found anti-BP180 autoantibody levels showed moderate correlation with objective BPDAI ( r = 0.56; 95% CI, 0.46-0.64) at baseline, strong correlation ( r = 0.63; 95% CI, 0.39-0.79) at 3-month follow-up, and moderate correlation ( r = 0.53; 95% CI, 0.25-0.72) at 6-month follow-up. Anti-BP180 autoantibody levels also showed moderate correlation ( r = 0.52; 95% CI, 0.39-0.62) with ABSIS at baseline, strong correlation ( r = 0.62; 95% CI, 0.39-0.79) at 3-month follow-up, and moderate correlation ( r = 0.53; 95% CI, 0.25-0.72) at 6-month follow-up. By contrast, anti-BP230 autoantibody levels showed no association with objective BPDAI and ABSIS at diagnosis and follow-up. The subgroup analysis found similar results when using different ELISA kits. Conclusions and Relevance The findings of this systematic review and meta-analysis indicated that anti-BP180 autoantibody levels may serve as an adjunctive tool for monitoring BP disease severity and guiding clinical care for patients with BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesPemphigoid, BullousHumansAutoantigensCollagen Type XVIIDystoninEnzyme-Linked Immunosorbent AssayImmunoglobulin GNon-Fibrillar CollagensSeverity of Illness Index

Substanzen

AutoantibodiesAutoantigensCollagen Type XVIIDST protein, humanDystoninImmunoglobulin GNon-Fibrillar Collagens

Autor:innen und Institutionen

  • Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
  • Department of Pharmacy, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
  • Department of Laboratory Medicine, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
  • Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan.
  • Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Department of Dermatology, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.

Zitieren

APA

Chou, P. Y., Yu, C. L., Wen, C. N., Tu, Y. K., & Chi, C. C. (2024). Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230. JAMA Dermatology, 160(11), 1192. https://doi.org/10.1001/jamadermatol.2024.3425

Vancouver

Chou PY, Yu CL, Wen CN, Tu YK, Chi CC. Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230. JAMA Dermatology. 2024;160(11):1192. doi:10.1001/jamadermatol.2024.3425

BibTeX
@article{Chou2024,
  author = {Chou, Po-Yi and Yu, Chia-Ling and Wen, Chiao-Ni and Tu, Yu-Kang and Chi, Ching-Chi},
  title = {Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230},
  journal = {JAMA Dermatology},
  year = {2024},
  volume = {160},
  number = {11},
  pages = {1192},
  doi = {10.1001/jamadermatol.2024.3425}
}
Kostenlos starten →